A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA
Cancer immunotherapy has shown significant potential in treating several malignancies by stimulating the host immune system to recognize and attack cancer cells. Immunogenic cell death (ICD) can amplify the antitumor immune responses and reverse the immunosuppressive tumor microenvironment, thus inc...
Saved in:
Main Authors: | Guojuan Sun, Ling He |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1498781/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-coding RNAs and exosomal ncRNAs in colorectal cancer
by: Yalda Zhoulideh
Published: (2025-02-01) -
Characterization of mammary glands and milk fat globule transcripts in lactating buffalo and goats
by: Hancai Jiang, et al.
Published: (2025-06-01) -
Silver nanoparticle induced immunogenic cell death can improve immunotherapy
by: Ara Sargsian, et al.
Published: (2024-11-01) -
Whole-transcriptome analysis reveals the profiles and roles of coding and non-coding RNAs during hair follicle cycling in Rex rabbits
by: Jie Wu, et al.
Published: (2025-01-01) -
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
by: Man Wang, et al.
Published: (2025-01-01)